FDA Approves First and Only Therapy for IgG4-RD ...Middle East

Medscape - News
FDA Approves First and Only Therapy for IgG4-RD
The CD19+ B-Cell targeted therapy reduced flare risk by 87% in a phase 3 clinical trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First and Only Therapy for IgG4-RD )

Also on site :